Sign in with Google. Opens in new tab
bullish
Alpha Generation Through Share Buybacks in Korea: Bi-Monthly (March and April 2025)
291 Views01 May 2025 07:54
In this insight, we discuss the alpha generation through companies that announced share buybacks in the Korean stock market in March and April 2025.
What is covered in the Full Insight:
- Introduction to Share Buybacks in Korea
- Overview of Companies Announcing Buybacks
- Notable Buyback Highlights
- Analysis of Companies Exceeding 3% Threshold
- Conclusion and Investor Recommendations
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- NTT DC REIT IPO: The Investment Case
- HSCI Index Rebalance Preview and Stock Connect (Sep 2025): Plenty of Recent IPOs Could Be Added
- Ohayo Japan | Jobs Data Lifts Wall Street to Record Highs
- Anjoy Foods Group A/H Trading - Cheap Price but Sluggish Demand
- [Japan M&A] YAGEO Extends Shibaura TOB Limbo at FSA/METI/BOJ Request on FEFTA
Top Unpaywalled Insights
More »- Oversupply Meets Tepid Demand Weighing Down on Soybean Meal
- [IO Technicals 2025/26] Bearish Momentum Intensifies
- "The Data Bottleneck in Quant Finance — and How to Break It" With David Forino, CTO of Quanted
- The New OS for Quant Finance: OpenBB, AI Agents & the Death of Legacy Terminals | New Barbarians ...
- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Celltrion Inc (068270 KS): Sequentially Weak 1Q25 Result; Momentum to Accelerate in 2H12 May 2025
- Celltrion (068270 KS): Record High Sales in 4Q; Sequentially Weaker Profit; Solid Outlook for 202526 Feb 2025
- Merger Between Celltrion Inc and Celltrion Pharm Is Cancelled16 Aug 2024
- Merger Between Celltrion Inc and Celltrion Healthcare (Phase I First)18 Aug 2023
x